3655 results for «214»

Filter By

3655 results

Management of residual and recurrent mitral regurgitation after TEER

12 Sep 2025 – From PCR Rio Valves 2025

Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.

Management of residual and recurrent mitral regurgitation after TEER

Tricuspid valve - Present and future perspectives: a critical appraisal

12 Sep 2025 – From PCR Rio Valves 2025

Explore the cutting-edge developments and practical insights in tricuspid valve interventions in this comprehensive session. Learn about the current status and patient selection for orthotopic valve implantation, gain expert guidance on intraprocedural monitoring with step-by-step tips, and understand the critical information required for pre, intra, and...

Integrating the newest valve guidelines into daily clinical reality

12 Sep 2025 – From PCR Rio Valves 2025

Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.

Watch the interview with Fabien...

Integrating the newest valve guidelines into daily clinical reality

Structural heart: demanding anatomies, difficult situations and unusual strategies

12 Sep 2025 – From PCR Rio Valves 2025

Navigate complex structural heart interventions through this session focusing on challenging anatomies and innovative procedural strategies. Topics include orthotopic tricuspid valve replacement amidst anatomical and physiological complexities, percutaneous closure of Valsalva sinus fistula, extreme TAVI approaches for pure aortic regurgitation, management of mitral paravalvular leaks with...

Advanced TAVI: techniques, timing, and problem-solving

12 Sep 2025 – From PCR Rio Valves 2025

Advance your knowledge in TAVI with this session addressing sophisticated techniques, procedural timing, and problem-solving in complex cases. Explore TAVI applications in rare quadricuspid valve anatomy with pure aortic insufficiency, strategic decision-making between TAVI and PCI, and innovative solutions for managing aortic stenosis in patients with...

TAVI - Take the first step considering life time management

12 Sep 2025 – From PCR Rio Valves 2025

Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.

TAVI - Take the first step considering life time management

Step-by-step TAVI in bicuspid aortic stenosis - LIVE case

29 Sep 2025 – From PCR Gulf Valves 2025

A 67-year-old woman with a history of atrial fibrillation and normal LV function presented with symptomatic paradoxical aortic valve stenosis. A 23 mm Sapien Resilia valve was implanted following predilatation with a 15 mm semi-compliant balloon.

LIVE Educational Case from Prince Sultan Cardiac Center - Riyadh, Saudi...

Step-by-step TAVI in bicuspid aortic stenosis - LIVE case

Mitral valve TEER echocardiography

29 Sep 2025 – From PCR Gulf Valves 2025

Gain essential knowledge in mitral valve TEER echocardiography through this comprehensive session focused on key echocardiographic views, image optimization for screening, criteria for suitability, and intraprocedural guidance. Enhance your skills with practical hands-on components aimed at improving procedural outcomes.

Tricuspid transcatheter therapies: the game changer

29 Sep 2025 – From PCR Gulf Valves 2025

Explore the evolving landscape of tricuspid transcatheter therapies in this comprehensive session reviewing tricuspid regurgitation etiology, anatomy, and current treatment options. Learn about various transcatheter tricuspid valve intervention devices, their strengths and limitations, and the critical diagnostic and intraprocedural imaging requirements to optimize patient selection and...

Tricuspid transcatheter therapies: the game changer

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Elad Asher

Author

Elad Asher
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

Cardiawave announces positive six-month data from valvosoft pivotal study at transcatheter cardiovascular therapeutics (TCT) conference

28 Oct 2024

EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

15 May 2024

Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)

03 Nov 2025

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Trish Singh

Author

Trish Singh
PROCTOR: PCI of native coronary artery vs SVGin patients with prior CABG
Didn’t find what you were looking for?